Exclusive

Publication

Byline

Singapore Clinical Trial: Phase 2b, Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Preceded by a Single Ascending Dose Portion and a Phase 2 Open-Label Portion, to Evaluate the Safety and Efficacy of Oral Infigratinib in Infants and Young Children with Achondroplasia

Singapore, July 4 -- The Health Sciences Authority received information related to the study titled 'Phase 2b, Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Preceded by a Single Ascendi... Read More


Singapore Clinical Trial: A Phase 3 Open-label Randomized Study Assessing the Efficacy and Safety of RLY-2608 + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for PIK3CA-mutant Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Locally Advanced or Metastatic Breast Cancer Following Recurrence or Progression On or After Treatment with a CDK4/6 Inhibitor

Singapore, July 4 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Open-label Randomized Study Assessing the Efficacy and Safety of RLY-2608 + Fulvestrant V... Read More


Singapore Clinical Trial: A randomized, double-blind, placebo-controlled study to evaluate the effect of dupilumab on airway inflammation through assessments of mucus plugging and other lung imaging parameters in patients with chronic obstructive pulmonary disease

Singapore, July 4 -- The Health Sciences Authority received information related to the study titled 'A randomized, double-blind, placebo-controlled study to evaluate the effect of dupilumab on airway ... Read More


Singapore Clinical Trial: CA088-1007: A Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of Arlocabtagene Autoleucel (BMS-986393), a GPRC5D-directed CAR-T Cell Therapy, Versus Standard Regimens in Adult Participants with Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

Singapore, July 4 -- The Health Sciences Authority received information related to the study titled 'CA088-1007: A Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety... Read More


Singapore Clinical Trial: A Multinational, Multicenter, Prospective, Randomized, Controlled, Open-Label, Phase 3 Study of Lutetium-177 (177Lu) Rosopatamab Tetraxetan in Combination with Standard of Care Versus Standard of Care Alone in Patients with Prostate-Specific Membrane Antigen (PSMA) Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) after Androgen Receptor Pathway Inhibitor (ARPI) Treatment

Singapore, July 4 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter, Prospective, Randomized, Controlled, Open-Label, Phase 3 Study of Lut... Read More


L&T Finance's Q1 retail disbursements rise 36%; loan book grows 28%

Mumbai, July 4 -- Urban Finance led the growth, with estimated disbursements rising 57% YoY to Rs 10,760 crore from Rs 6,851 crore a year ago. Rural Business Finance disbursements increased 24% YoY to... Read More


మిక్స్‌డ్ టాక్, షాకింగ్‌గా అలియా భట్ ఆల్ఫా డే 1 కలెక్షన్స్- స్పై యూనివర్స్ చరిత్రలోనే అత్యల్పం- ఎన్ని కోట్లు వచ్చాయంటే?

భారతదేశం, జూలై 4 -- Alia Bhatt Alpha 1st Day Worldwide Box Office Collection: భారతీయ సినీ పరిశ్రమలో అత్యంత భారీ ఫ్రాంచైజీగా గుర్తింపు తెచ్చుకున్న వైఆర్ఎఫ్ స్పై యూనివర్స్ నుంచి ఎప్పుడెప్పుడా అని ఎదురుచ... Read More


AUEET 2026 : ఆంధ్ర యూనివర్సిటీలో ఇంజినీరింగ్ ప్రవేశాలకు సెకండ్ ఫేజ్ షెడ్యూల్ విడుదల

భారతదేశం, జూలై 4 -- ఆంధ్ర విశ్వవిద్యాలయం AUEET 2026 సెకండ్ ఫేజ్ కౌన్సెలింగ్ షెడ్యూల్‌ను విడుదల చేసింది. వెబ్ కౌన్సెలింగ్ జూలై 4, 2026న audoa.andhrauniversity.edu.inలో ప్రారంభమైంది. మొదటి దశలో సీటు పొం... Read More


Ultraviolette dispatches 653 motorcycles in June; X-47 accounts for nearly 90% of sales

India, July 4 -- Ultraviolette dispatched 653 motorcycles in June 2026, with the X-47 crossover making up a big chunk of its wholesale volumes. Wholesale data shows the electric crossover accounted fo... Read More


Lessons from the green revolution: Let's not repeat the mistakes with the bio revolution

New Delhi, July 4 -- India's Green Revolution remains one of the defining achievements of modern agriculture. In the span of a few decades, the country transformed itself from a food-deficit nation de... Read More